Document is current
Any future updates will be listed below
-
Authors
L’Her, Erwan
Teiten, Christelle
Bailly, Pierre
- License Information
-
More Information
Article History
Received: 14 July 2025
Accepted: 5 August 2025
First Online: 14 August 2025
Declarations
:
: Pr Erwan L’HER (ELH) is consultant for Sedana Medical and has received grants for an ongoing study about the use of isoflurane within the ICU; he is also consultant for GE Healthcare, co-founder and share-holder of Oxynov Inc. Canada and Ivanae Médical, France outside the current topicDr Christelle Teiten (CT) has no competing interestDr Pierre Bailly (PB) is the main investigator of the Inased study, promoted by CHRU de Brest and granted by Sedana; he has no other competing interest.
: Not applicable.
: Not applicable.
